MENU
IBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iBio (IBIO) Ownership - Who owns iBio?
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.27M
P/E Ratio
0.65
Total Cash
4.96M
Projected Growth
N/A
Total Debt
3.76M
Revenue
375K
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
IBIO
Capitalization
16.3M
P/E Ratio
0.65
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
4.96M
Total Cash/Share
0.30
Total Debt
3.76M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
375K
ROE
N/A
Book Value
11.4M
P/B Ratio
1.43
Cash Flow
N/A
Earnings
-0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
1.12
Current Revenue Per Employee
12500.00
Dividends Per Share - Security
N/A
EBITDA
-15.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.41
Revenue To Assets
-60.62
Shares Held By Institutions
5.26M
Shares Outstanding - Current
16.5M
Total Liabilities
7.72M
Total Volume MTD
N/A
Value
1
Gain YTD
-62.184
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the development and commercialization of vaccines and therapeutic proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A